FATTY ACID-BINDING PROTEIN LEVEL AND CONCENTRATION OF ANTI-MYOCARDIUM ANTIBODIES IN PATIENTS WITH CARDIAC ARRHYTHMIAS
Abstract
To assess the serum levels of cardiac fatty-acid binging protein and anti-myocardial auto-antibodies in arrhythmic patients, 80patients with paroxysmal and chronic atrial fibrillation, atrio-ventricular nodal tachycardia, and Wolff-Parkinson-White syndrome were examined.
About the Authors
R. E. Batalov
ГУ НИИ кардиологии ТНЦ СО РАМН, Томск
Russian Federation
Russian Federation
T. E. Suslova
ГУ НИИ кардиологии ТНЦ СО РАМН, Томск
Russian Federation
Russian Federation
I. V. Kologrivova
ГУ НИИ кардиологии ТНЦ СО РАМН, Томск
Russian Federation
Russian Federation
А. Дедкова
ГУ НИИ кардиологии ТНЦ СО РАМН, Томск
Russian Federation
Russian Federation
I. V. Antonchenko
ГУ НИИ кардиологии ТНЦ СО РАМН, Томск
Russian Federation
Russian Federation
S. V. Popov
ГУ НИИ кардиологии ТНЦ СО РАМН, Томск
Russian Federation
Russian Federation
References
1. Адо А.Д., Новицкий В.В. Патологическая физиология. Изд. Томского Университета. - 1994. - 468 с.
2. Бойцов С.А., Дерюгин М.В., Сухов В.Ю. Клиническая оценка данных сцинтиграфии с аутолейкоцитами, меченными 99тТс-ГМПАО, у больных с малосимптомными неревматическими миокардитами // Кардиология. - 2001. -№ 11 - С. 48-52.
3. Кушаковский М. С. Фибрилляция предсердий (причины, механизмы, клинические формы, лечение и профилактика). СПб.: ИКФ «Фолиант», 1999. - 176 с.
4. Caforio A.L.P., Mahon N.J. Circulating cardiac antibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance // Eur. J. Heart Fail. - 2002. - Vol. 4. - P. 411-417.
5. Frustaci A., Chimenti C., Belloci F. et al. Histological substrat of atrial biopsies in patients with lone atrial fibrillation // Circulation. - 1997. - Vol. 96. - P. 1180-1184.
6. Glatz J.F.C., van der Voort D., Hermens W. T. Fatty Acid-binding protein as the Earliest Available Plasma Marker of Acute Myocardial Injury // Journal of Clinical Ligand Assay. - 2002. - Vol. 25. - P. 167-177.
7. Hermens W.T. Mechanisms of protein release from injured heart muscle// Dev Cardiovasc. Med. - 1998. - Vol. 205. - P. 85-98
8. Liao L., Sindhwani R., Rojkind M. et al. Antibody-mediated autoimmune myocarditis depends on genetically determined target organ sensitivity // J. Exp. Med. - 1995. - Vol. 181. - P. 1123-1131.
9. Limas C.J., Goldenberg I.E., Limas C. Autoantibodies against P-adrenoreceptors in human idiopathic dilated cardiomyopathy // Circulat. Res. - 1989. - Vol. 64. - P. 97-103.
10. Maisch B., Deeg P., Liebau G., et al. Diagnostics relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy // Am. J. Cardiol. - 1983. - Vol. 52. - P. 1072-1108.
11. Ristic A., Maisch B. Cardiac arrythm and conduction disturbances: what is the role of autoimmune mechanisms? // Herz. - 2000. - №3. - P. 181-188.
12. Rose N.R., Bona C. Defining criteria for autoimmune disease (Witebsky’s postulates revisited) // Immunol. Today. - 1991. - Vol. 14. - P. 426-428.
13. Strain J. Results of endomyocardial biopsy in patients with spontaneous ventricular tachycardia but without apparent structural heart disease // Circulation. - 2001. - Vol. 104. - P. 2886-2891.
14. Takeda S., Kashiwagi H., Kajiwara H. et al. Prognostic value of Heart Fatty Acid-Binding Protein for Chest Symptom Patients in Emergency Room // AHA. - 2003; Abstract 2653.
Review
For citations:
Batalov R.E., Suslova T.E., Kologrivova I.V., , Antonchenko I.V., Popov S.V. FATTY ACID-BINDING PROTEIN LEVEL AND CONCENTRATION OF ANTI-MYOCARDIUM ANTIBODIES IN PATIENTS WITH CARDIAC ARRHYTHMIAS. Journal of Arrhythmology. 2007;(50):21-24. (In Russ.)
Views:
116
Email this article 